Retinitis Pigmentosa
Showing 1 - 25 of 178
Glaucoma, Age-related Macular Degeneration, Retinitis Pigmentosa Trial in Guangzhou (New head-mounted visual aids)
Not yet recruiting
- Glaucoma
- +3 more
- New head-mounted visual aids
-
Guangzhou, Guangdong, ChinaZhongshan Ophthalmic Center, Sun Yat-sen University
Oct 7, 2023
Study in Subjects Who Received vMCO-I Administered Via
Enrolling by invitation
- Retinitis Pigmentosa
- +2 more
- Gene Therapy product:vMCO-I
-
Cuttack, Odisha, IndiaJPM Rotary Club of Cuttack Eye Hospital and Research Institute
Jun 26, 2023
Age-Related Macular Degeneration, Retinitis Pigmentosa, Ultrasound Therapy; Complications Trial (Non-invasive ultrasound retinal
Not yet recruiting
- Age-Related Macular Degeneration
- +2 more
- Non-invasive ultrasound retinal stimulation Device
- (no location specified)
Jun 19, 2023
Retinitis Pigmentosa Trial (1.5 x 10^6 UC-MSC + CM, 5 x 10^6 UC-MSC + CM)
Not yet recruiting
- Retinitis Pigmentosa
- 1.5 x 10^6 UC-MSC + CM
- 5 x 10^6 UC-MSC + CM
- (no location specified)
Jun 11, 2023
Retinitis Pigmentosa Trial in Shanghai (AuTNA I)
Recruiting
- Retinitis Pigmentosa
- AuTNA I
-
Shanghai, Shanghai, ChinaChunhui Jiang
May 2, 2023
Retinitis Pigmentosa Patients
Not yet recruiting
- Retinitis Pigmentosa
- (no location specified)
Apr 28, 2023
Retinitis Pigmentosa Trial (2C-QD, Sham 2C-QD)
Not yet recruiting
- Retinitis Pigmentosa
- 2C-QD
- (no location specified)
Apr 24, 2023
Assess the Reliability and Validity of the MLYMT
Recruiting
- Retinitis Pigmentosa
- Retinal Dystrophy
- Observational
-
Beverly Hills, California
- +6 more
Apr 18, 2023
Study of BEST1 Vitelliform Macular Dystrophy
Recruiting
- Best Vitelliform Macular Dystrophy
- Retinitis Pigmentosa
- Natural History Study
-
New York, New York
- +2 more
Mar 30, 2023
Retinitis Pigmentosa Trial in Ankara (Wharton's jelly derived mesenchymal stemcells, Magnovision)
Completed
- Retinitis Pigmentosa
- Wharton's jelly derived mesenchymal stemcells
- Magnovision
-
Ankara, Gölbaşı, Turkey
- +2 more
Mar 23, 2023
Inherited Retinal Dystrophies Using Whole Genome Sequencing and
Recruiting
- Inherited Retinal Dystrophy
- +2 more
- whole genome sequencing
-
Rome, ItalyIstituto Superiore di Sanità-Dpt. Oncology and Molecular Medicin
Mar 30, 2023
UC-MSC Transplantation in Patients With Retinitis Pigmentosa
Enrolling by invitation
- Retinitis Pigmentosa
- Conditioned Medium (CM)
- Umbilical Cord Mesenchymal Stem Cell (UC-MSC)
-
Jakarta, DKI Jakarta, Indonesia
- +1 more
Mar 14, 2023
Retinitis Pigmentosa, Stem Cell Transplant Trial in Istanbul (Stem cell implantation)
Completed
- Retinitis Pigmentosa
- Stem Cell Transplant
- Stem cell implantation
-
Istanbul, TurkeyAcıbadem University
Jan 25, 2023
Study of Retinal Dystrophies Associated With Rare
Active, not recruiting
- Inherited Retinal Degeneration
- Retinitis Pigmentosa
-
Phoenix, Arizona
- +23 more
Jan 24, 2023
Retinitis Pigmentosa, Retinitis Pigmentosa Syndrome Trial in United States (EA-2353)
Recruiting
- Retinitis Pigmentosa
- Retinitis Pigmentosa Syndrome
-
Miami, Florida
- +5 more
Jan 24, 2023
Cell Collection to Study Eye Diseases
Recruiting
- Retinal Disease
- +3 more
-
Bethesda, MarylandNational Institutes of Health Clinical Center
Jan 23, 2023
Retinitis Pigmentosa Trial in Tel Hashomer (Alga Dunaliella Bardawil, Placebo (starch))
Active, not recruiting
- Retinitis Pigmentosa
- Alga Dunaliella Bardawil
- Placebo (starch)
-
Tel Hashomer, IsraelSheba Medical Center
Jan 15, 2023
Objective Perimetry Using Chromatic Multifocal Pupillometer
Recruiting
- Retinal Dystrophies
- +2 more
-
Tel HaShomer, IsraelSheba Medical Center
Jan 15, 2023
Retinitis Pigmentosa Trial in Paris (Human Embryonic Stem Cell Derived Retinal Pigment Epithelium (RPE))
Active, not recruiting
- Retinitis Pigmentosa
- Human Embryonic Stem Cell Derived Retinal Pigment Epithelium (RPE)
-
Paris, France•Centre Hospitalier National d'Ophtalmologie (CHNO) des Quinze-V
Jan 11, 2023
Retinitis Pigmentosa, Usher Syndrome Type 2 Trial in Canada, France, United States (RNA antisense oligonucleotide for
Terminated
- Retinitis Pigmentosa
- Usher Syndrome Type 2
- RNA antisense oligonucleotide for intravitreal injection
-
Boston, Massachusetts
- +6 more
Dec 12, 2022
Retinitis Pigmentosa Trial (KIO-301)
Recruiting
- Retinitis Pigmentosa
-
Adelaide, South Australia, AustraliaRoyal Adeliade Hospital
Dec 22, 2022
Retinitis Pigmentosa Trial in Tuebingen (subretinal injection of rAAV.hPDE6A)
Active, not recruiting
- Retinitis Pigmentosa
- subretinal injection of rAAV.hPDE6A
-
Tuebingen, GermanyUniversitätsklinikum Tübingen, Department für Augenheilkunde
Dec 7, 2022
Retinal Disease, Age-Related Macular Degeneration, Retinitis Pigmentosa Trial in Westport, Coral Springs, Dubai (Arm 1)
Recruiting
- Retinal Disease
- +17 more
- Arm 1
-
Westport, Connecticut
- +2 more
Nov 25, 2022